<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Emerging scientific evidence has disclosed unsuspected influences between iron metabolism and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The relationship is bi-directional--iron affects <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism, and <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism impinges on several iron metabolic pathways </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> and inflammatory cytokines influence these relationships, amplifying and potentiating the initiated events </plain></SENT>
<SENT sid="3" pm="."><plain>The clinical impact of these interactions depends on both the genetic predisposition and the time frame in which this network of closely related signals acts </plain></SENT>
<SENT sid="4" pm="."><plain>In recent years, increased iron stores have been found to predict the development of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> while iron <z:mpath ids='MPATH_63'>depletion</z:mpath> was protective </plain></SENT>
<SENT sid="5" pm="."><plain>Iron-induced damage might also modulate the development of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0002055'>diabetes</z:mp> complications </plain></SENT>
<SENT sid="6" pm="."><plain>Iron <z:mpath ids='MPATH_63'>depletion</z:mpath> has been demonstrated to be beneficial in coronary artery responses, <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e>, insulin secretion, insulin action, and metabolic control in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Here, we show that iron modulates insulin action in healthy individuals and in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>The extent of this influence should be tested in large-scale clinical trials, searching for the usefulness and cost-effectiveness of therapeutic measures that decrease iron toxicity </plain></SENT>
<SENT sid="9" pm="."><plain>The study of individual susceptibility and of the mechanisms that influence tissue <z:mpath ids='MPATH_41'>iron deposition</z:mpath> and damage are proposed to be valuable in anticipating and treating <z:mp ids='MP_0002055'>diabetes</z:mp> complications </plain></SENT>
</text></document>